8-K: Current report filing
Published on June 8, 2006
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): June 5, 2006
Access Pharmaceuticals, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-9314 83-0221517
- ------------------------ ------------------------ -------------------
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
2600 Stemmons Freeway, Suite 176, Dallas, Texas 75207
----------------------------------------------- ---------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (214) 905-5100
--------------
Item 3.03 Material Modification to Rights of Securitiy Holders
-----------------------------------------------------
Access completed a one-for-five reverse stock split of the Company's
common stock par value $0.01 per share on June 6, 2006.
Item 7.01 Regulation FD Disclosure
------------------------
Access issued a press release on June 6, 2006, a copy of which is
attached as Exhibit 99.1 to this report and incorporated herein by this
reference, in which it announced the its one-for-five reverse stock
split of the Company's common stock.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Access Pharmaceuticals, Inc.
(Registrant)
By: /s/ Stephen B. Thompson
------------------
Stephen B. Thompson
Vice President and
Chief Financial Officer
Dated June 8, 2006
EXHIBIT INDEX
Exhibit
Number Description
- ------- ------------
99.1 Press Release, dated June 8, 2006